Article Text

Download PDFPDF
Review: aspirin does not reduce CV events but may reduce non-fatal stroke in peripheral artery disease

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


In patients with peripheral artery disease (PAD), does aspirin reduce cardiovascular (CV) events?

Review scope

Included studies compared aspirin with placebo or control for reducing CV events in patients with PAD. Outcomes were a composite end point of non-fatal myocardial infarction (MI), non-fatal stroke, and CV mortality; individual components of the composite end point; all-cause …

View Full Text


  • Source of funding: National Heart, Lung, and Blood Institute.